The p38alpha MAPK pathway : a key factor in colorectal cancer progression and treatment
Colorectal cancer (CRC) remains one of the most common malignancies in the world. Development of resistance to conventional therapies is frequently observed in advanced stages of the disease and frequently involves MAPK signaling. Recent studies identified p38a. MAPK as a mediator of resistance to i...
| Main Author: | |
|---|---|
| Published: |
Open University
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664279 |